Abstract
Genetics and proteomics determine structure and function of normal tissues, and the molecular alterations that underlie tumorigenesis result in changes in these aspects of tissue biology in neoplasms. We review the known genetic alterations in pituitary tumors. These include the oncogenic Gsα protein (GSP)-activating mutations, and pituitary tumor-derived fibroblast growth factor receptor-4 (ptd-FGFR4), as well as tumor suppressor gene mutations associated with multiple endocrine neoplasia type 1 (MEN1). Other candidates identified from expression profiling include pituitary tumor-transforming gene (PTTG), GADD45, and bone morphogenic protein (BMP)4. Proteomic changes in pituitary tumors include classical alterations identified by immunohistochemistry as well as epigenetic reductions in p27. The underlying mechanisms for dysregulated cell adhesive molecules including cadherins and FGFRs are reviewed. The combined use of genetic and proteomic approaches will enhance novel drug therapeutic development.
Similar content being viewed by others
References
Ezzat, S. (2001). Brain Pathol. 11, 356–370.
Asa, S. L. and Ezzat, S. (1998). Endocr. Rev. 19, 798–827.
Asa, S. L. and Ezzat, S. (2002). Nat. Rev. Cancer 2, 836–849.
Spada, A., Vallar, L., and Faglia, G. (1992). Trends Endocrinol. Metab. 3, 355–360.
Hayward, B. E., Barlier, A., Korbonits, M., et al. (2001). J. Clin. Invest. 107, R31-R36.
Landis, C. A., Harsh, G., Lyons, J., Davis, R. L., McCormick, F., and Bourne, H. R. (1990). J. Clin. Endocrinol. Metab. 71, 1416–1420.
Spada, A., Arosio, M., Bochicchio, D., et al. (1990). J. Clin. Endocrinol. Metab. 71, 1421–1426.
Ezzat, S., Kontogeorgos, G., Redelmeier, D. A., Horvath, E., Harris, A. G., and Kovacs, K. (1995). Eur. J. Endocrinol. 133, 686–690.
Harris, P. E., Alexander, J. M., Bikkal, H. A., et al. (1992). J. Clin. Endocrinol. Metab. 75, 918–923.
Oyesiku, N. M., Evans, C.-O., Brown, M. R., Blevins, L. S., Tindall, G. T., and Parks, J. S. (1997). J. Clin. Endocrinol. Metab. 82, 4184–4188.
Sano, T., Asa, S. L., and Kovacs, K. (1988). Endocr. Rev. 9, 357–373.
Asa, S. L., Kovacs, K., Stefaneanu, L., et al. (1992). Endocrinology 131, 2083–2089.
Thapar, K., Kovacs, K., Stefaneanu, L., et al. (1997). Am. J. Pathol. 151, 769–784.
Ezzat, S., Asa, S. L., Stefaneanu, L., et al. (1994). J. Clin. Endocrinol. Metab. 78, 555–560.
Abbass, S. A. A., Asa, S. L., and Ezzat, S. (1997). J. Clin. Endocrinol. Metab. 82, 1160–1166.
Yu, S., Asa, S. L., Weigel, R. J., and Ezzat, S. (2003). J. Biol. Chem. 278, 19597–19602.
Ezzat, S., Yu, S., and Asa, S. L. (2003). Am. J. Pathol. 163, 1177–1184.
Ezzat, S., Zheng, L., Zhu, X. F., Wu, G. E., and Asa, S. L. (2002). J. Clin. Invest. 109, 69–78.
Qian, Z. R., Sano, T., Asa, S. L., et al. (2004). J. Clin. Endocrinol. Metab. 89, 1904–1911.
Zhuang, Z., Ezzat, S., Vortmeyer, A. O., et al. (1997). Cancer Res. 57, 5446–5451.
Asa, S. L., Somers, K., and Ezzat, S. (1998). J. Clin. Endocrinol. Metab. 83, 3210–3212.
Pei, L. and Melmed, S. (1997). Mol. Endocrinol. 11, 433–441.
Zou, H., McGarry, T. J., Bernal, T., and Kirschner, M. W. (1999). Science 285, 418–422.
Evans, C. O., Young, A. N., Brown, M. R., et al. (2001). J. Clin. Endocrinol. Metab. 86, 3097–3107.
Zhang, X., Sun, H., Danila, D. C., et al. (2002). J. Clin. Endocrinol. Metab. 87, 1262–1267.
Paez-Pereda, M., Giacomini, D., Refojo, D., et al. (2003). Proc. Natl. Acad. Sci. USA 100, 1034–1039.
Michiels, F. M., Caillou, B., Talbot, M., et al. (1994). Proc. Natl. Acad. Sci. USA 91, 10488–10492.
Crabtree, J. S., Scacheri, P. C., Ward, J. M., et al. (2001). Proc. Natl. Acad. Sci. USA 98, 1118–1123.
Asa, S. L. and Ezzat, S. (1999). Pituitary 1, 159–168.
Asa, S. L. and Ezzat, S. (2004). Front. Horm. Res. 32, 1–19.
Bhayana, S., Booth, G., Kovacs, K., Asa, S. L., and Ezzat, S. (2005). J. Clin. Endocrinol. Metab., in press.
Nakayama, K., Ishida, N., Shirane, M., et al. (1996). Cell 85, 707–720.
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., et al. (1996). Cell 85, 721–732.
Fero, M. L., Rivkin, M., Tasch, M., et al. (1996). Cell 85, 733–744.
Franklin, D. S., Godfrey, V. L., Lee, H., et al. (1998). Genes Develop. 12, 2899–2911.
Jin, L., Qian, X., Kulig, E., et al. (1997). Am. J. Pathol. 151, 509–519.
Bamberger, C. M., Fehn, M., Bamberger, A. M., et al. (1999). Eur. J. Endocrinol. 140, 250–255.
Dahia, P. L., Aguiar, R. C., Honegger, J., et al. (1998). Oncogene 16, 69–76.
Lidhar, K., Korbonits, M., Jordan, S., et al. (1999). J. Clin. Endocrinol. Metab. 84, 3823–3830.
Simpson, D. J., Bicknell, J. E., McNicol, A. M., Clayton, R. N., and Farrell, W. E. (1999). Genes Chromosomes Cancer 24, 328–336.
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A. (1992). Nature 359, 295–300.
Zhu, J., Leon, S. P., Beggs, A. H., Busque, L., Gilliland, D. G., and Black, P. M. (1994). J. Clin. Endocrinol. Metab. 78, 922–927.
Simpson, D. J., Hibberts, N. A., McNicol, A. M., Clayton, R. N., and Farrell, W. E. (2000). Cancer Res. 60, 1211–1216.
Cavallaro, U., Niedermeyer, J., Fuxa, M., and Christofori, G. (2001). Nat. Cell Biol. 3, 650–657.
Ezzat, S., Zheng, L., and Asa, S. L. (2004). Mol. Endocrinol. 18, 2543–2552.
Daniel, L., Trouillas, J., Renaud, W., et al. (2000). Cancer Res. 60, 80–85.
Fujimoto, I., Bruses, J. L., and Rutishauser, U. (2001). J. Biol. Chem. 276, 31745–31751.
Qian, Z. R., Li, C. C., Yamasaki, H., et al. (2002). Mod. Pathol. 15, 1357–1365.
Asa, S. L. (1998). Tumors of the pituitary gland. Atlas of tumor pathology, Third Series, Fascicle 22. Armed Forces Institute of Pathology: Washington, DC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asa, S.L., Ezzat, S. Genetics and proteomics of pituitary tumors. Endocr 28, 43–47 (2005). https://doi.org/10.1385/ENDO:28:1:043
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:28:1:043